BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Response to oxidative stress
,
Obesity
,
Prostate
,
Neocentromeres
,
Tamoxifen
,
rs6983267
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Tarceva
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
MIR-7 overexpression in head and neck cancer cell lines
Explore Curated Studies Results
Literature
Most Relevant Literature
The combination of bevacizumab/Avastin and erlotinib/Tarceva is relevant for the treatment of metast…
MiRNA-7 Replacement Effect on Proliferation and Tarceva-Sensitivity in U373-MG Cell Line.
LKB1 mutations are not associated with the efficacy of first-line and second-line chemotherapy in pa…
Gene mutation characteristics of nonsmall-cell lung carcinoma patients with wild-type epidermal grow…
EGFR mutations predict a favorable outcome for malignant pleural effusion of lung adenoc…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Tarceva With or Without Apatinib in the Advanced Lung Adenocarcinoma
OSI-774 (Erlotinib, Tarceva) in Elderly Patients
Avastin and Tarceva for Locally Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer
Phase I/II Trial of Radiation, Avastin and Tarceva for Pancreatic Adenocarcinoma
Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ